Implementation of Nurse-Driven HIV Screening Targeting Key Populations in Emergency Departments: A Multilevel Analysis From the DICI-VIH Trial.
Authors of this article are:
Leblanc J, Côté J, Pagé MG, Piquet H, Simon T,0, Crémieux AC,; DICI-VIH (Dépistage Infirmier CIblé du VIH) Group.
A summary of the article is shown below:
BACKGROUND: In countries with concentrated HIV epidemics, optimizing screening to reach individuals with undiagnosed infection is essential. The DICI-VIH study, a cluster-randomized crossover trial conducted in eight French emergency departments (EDs), found that a strategy combining nurse-driven targeted HIV screening with routine diagnostic testing was effective.AIM: The aim was to investigate factors associated with the implementation of HIV screening targeting key populations in EDs.METHODS: A self-administered questionnaire was distributed at registration to patients aged 18-64 years and able to give consent during the DICI-VIH intervention. Based on their responses, those belonging to key populations were offered a rapid test by triage nurses. Two key stages of the process were evaluated: questionnaire distribution by providers and test acceptance by patients. Patient information, daily workload, and ED characteristics were collected. The associations between these variables and (a) the proportion of questionnaires distributed and (b) the proportion of tests accepted were evaluated using multilevel modeling in order to examine differences in screening implementation between EDs.RESULTS: Questionnaire distribution proportions varied from 23% to 48% across EDs. They were higher on weekdays than weekends (odds ratio, OR: 3.77; 95% CI: 3.57-3.99) and when research staff participated (OR: 1.31; 95% CI: 1.26-1.37). They decreased over time (OR: 0.76; 95% CI: 0.71-0.82; 4th [Q3] vs. 1st quartile [Q0] of intervention days) and with increased patient flow (OR: 0.61; 95% CI: 0.56-0.67; Q3 vs. Q0 of eligible patients). Test acceptance varied from 64% to 77% across EDs, increased with research staff participation (OR 1.20; 95% CI: 1.03-1.40), and decreased over time (OR: 0.75; 95% CI: 0.60-0.92; Q3 vs. Q0). Patients who accepted were more likely to be younger (OR: 0.76; 95% CI: 0.61-0.96; 50-64-year-old vs. 30-39-year-old patients).LINKING EVIDENCE TO ACTION: Patient flow, intervention duration, weekdays, and research staff participation were important determinants of targeted screening implementation. These findings could help guide future implementation in similar settings.© 2019 Sigma Theta Tau International.
Check out the article’s website on Pubmed for more information:
[link-preview url=https://www.ncbi.nlm.nih.gov/pubmed/31478309 forceshot=true]
This article is a good source of information and a good way to become familiar with topics such as: HIV; emergency service, hospital; mass screening; nurses; prevention and control; targeted screening.
NativeFolder: The Only Bacterial Culture Medium for the Expression of Soluble Proteins
-
- Sale!
- Molecular Biology, Research Kits
NativeFolder Bacterial Culture Medium
- Original price was: $795.00.$295.00Current price is: $295.00.
Interference Test Kit for Assay Validation
-
- Sale!
- Interference, Research Kits
Interference Test Kit
- Original price was: $995.00.$495.00Current price is: $495.00.
Rheumatoid Factor Interference Blocker
-
- Sale!
- Antibodies, Interference
Rheumatoid Factor Interference Blocker
- Original price was: $595.00.$395.00Current price is: $395.00.
New Antibodies from MOLECULAR DEPOT
-
- Sale!
- Antibodies
Zebrafish wnt8b Antibody (Center)
- Original price was: $1,295.00.$695.00Current price is: $695.00.
-
- Sale!
- Antibodies
TRIB2 Antibody (N-Term)
- Original price was: $1,295.00.$695.00Current price is: $695.00.
-
- Sale!
- Antibodies
NTN1 Antibody (C-Term)
- Original price was: $1,295.00.$695.00Current price is: $695.00.
-
- Sale!
- Antibodies
NME1 Antibody
- Original price was: $1,295.00.$695.00Current price is: $695.00.
-
- Sale!
- Antibodies
Parp9 Antibody (C-Term)
- Original price was: $1,295.00.$695.00Current price is: $695.00.
-
- Sale!
- Antibodies
CDK1 Antibody
- Original price was: $1,295.00.$695.00Current price is: $695.00.
-
- Sale!
- Antibodies
DANRE hoxc11a Antibody (N-Term)
- Original price was: $1,295.00.$695.00Current price is: $695.00.
-
- Sale!
- Antibodies
VDR Antibody (Center)
- Original price was: $1,295.00.$695.00Current price is: $695.00.
-
- Sale!
- Antibodies
ITIH4 Antibody (C-Term)
- Original price was: $1,295.00.$695.00Current price is: $695.00.
-
- Sale!
- Antibodies
SEMA4B Antibody (C-Term)
- Original price was: $1,295.00.$695.00Current price is: $695.00.
New Proteins from MOLECULAR DEPOT
-
- Sale!
- Conjugates, Proteins
Captopril HSA Biotin Conjugate
- Original price was: $1,995.00.$995.00Current price is: $995.00.
-
- Sale!
- Proteins
PKC-α, Active, GST-tagged from Xanopus sp.
- Original price was: $1,595.00.$795.00Current price is: $795.00.
-
- Sale!
- Conjugates, Proteins
Prilocain BSA Biotin Conjugate
- Original price was: $1,995.00.$995.00Current price is: $995.00.
-
- Sale!
- Conjugates, Proteins
T3 (Triiodothyronine) BSA Biotin Conjugate
- Original price was: $1,995.00.$995.00Current price is: $995.00.
-
- Sale!
- Conjugates, Proteins
Pipemidic Acid BSA Biotin Conjugate
- Original price was: $1,995.00.$995.00Current price is: $995.00.
-
- Sale!
- Proteins
PKD2 Protein, Active (Recombinant Human)
- Original price was: $1,795.00.$895.00Current price is: $895.00.
-
- Sale!
- Conjugates, Proteins
Meropenem BSA Biotin Conjugate
- Original price was: $1,995.00.$995.00Current price is: $995.00.
-
- Sale!
- Conjugates, Proteins
Piperacillin BSA Biotin Conjugate
- Original price was: $1,995.00.$995.00Current price is: $995.00.
-
- Sale!
- Proteins
Protein A Peroxidase from Staphylococcus aureus/horseradish
- Original price was: $1,195.00.$595.00Current price is: $595.00.
-
- Sale!
- Conjugates, Proteins
Tobramycin BSA Biotin Conjugate
- Original price was: $1,995.00.$995.00Current price is: $995.00.
New Chemicals from MOLECULAR DEPOT
-
- Sale!
- Chemicals, Interference, Lipids
Triglyceride Mix for Interference Testing
- Original price was: $895.00.$395.00Current price is: $395.00.
-
- Sale!
- Chemicals
Microparticle Stabilizer Solution
- Price range: $295.00 through $495.00
-
- Sale!
- Buffers & Solutions, Chemicals
Enzyme Acceptor Stabilization Buffer
- Original price was: $495.00.$250.00Current price is: $250.00.
-
- Sale!
- Buffers & Solutions, Chemicals
Enzyme Donor Stabilization Buffer
- Original price was: $495.00.$250.00Current price is: $250.00.
-
- Sale!
- Chemicals, Conjugates
Progesterone Biotin Conjugate Solution
- Original price was: $995.00.$595.00Current price is: $595.00.
-
- Sale!
- Buffers & Solutions, Chemicals
Microparticle Activation Buffer
- Price range: $395.00 through $695.00
-
- Sale!
- Buffers & Solutions, Chemicals
Microparticle Washing Buffer
- Price range: $395.00 through $695.00
-
- Sale!
- Buffers & Solutions, Chemicals
Microparticle Blocking Buffer
- Price range: $395.00 through $695.00
-
- Sale!
- Buffers & Solutions, Chemicals
Latex Microparticles Anti Aggregation Agent
- Price range: $295.00 through $3,500.00
-
- Sale!
- Chemicals
CPRG (Chlorophenol red-β-D-galactopyranoside)
- Original price was: $850.00.$395.00Current price is: $395.00.






































